Ward P.J. Jansen
A5073676497- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- ECG Monitoring and Analysis
- Cardiac electrophysiology and arrhythmias
- Acute Myocardial Infarction Research
- Neurological disorders and treatments
- Cardiac Structural Anomalies and Repair
- Healthcare cost, quality, practices
- Infective Endocarditis Diagnosis and Management
- Coronary Interventions and Diagnostics
- Hemodynamic Monitoring and Therapy
- Venous Thromboembolism Diagnosis and Management
- Heart Rate Variability and Autonomic Control
- Cardiovascular Syncope and Autonomic Disorders
- Orthopedic Surgery and Rehabilitation
- Botulinum Toxin and Related Neurological Disorders
- Cardiomyopathy and Myosin Studies
- Cardiac Valve Diseases and Treatments
- Cardiac Health and Mental Health
Tergooi
2020-2024
TeleCheck-AF is a multicentre international project initiated to maintain care delivery for patients with atrial fibrillation (AF) during COVID-19 through teleconsultations supported by an on-demand photoplethysmography-based heart rate and rhythm monitoring app (FibriCheck®). We describe the characteristics, inclusion rates, experiences from participating centres according infrastructure as well characteristics recruited patients.Three surveys exploring centre (n = 25), 23), patient 826)...
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent transvenous ICD (TV-ICD) therapy. PRAETORIAN trial demonstrated that the S-ICD non-inferior TV-ICD with regard combined primary endpoint of inappropriate shocks complications. This prespecified secondary analysis evaluates all in trial.The an international, multicentre, randomized which 849 patients indication for therapy were receive S- (N =...
The PRAETORIAN trial (A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) showed noninferiority subcutaneous implantable cardioverter defibrillator (S-ICD) compared with transvenous (TV-ICD) regard to inappropriate shocks complications. In contrast TV-ICD, S-ICD cannot provide antitachycardia pacing for monomorphic ventricular tachycardia. This prespecified secondary analysis evaluates appropriate therapy whether reduces the...
Within the TeleCheck-AF project, numerous centres in Europe used on-demand photoplethysmography (PPG) technology to remotely assess heart rate and rhythm conjunction with teleconsultations. Based on investigator experiences, we aimed develop an educational structured stepwise practical guide how interpret PPG signals introduce typical clinical scenarios was used.
Background: The PRAETORIAN trial investigated the efficacy and safety of subcutaneous implantable cardioverter-defibrillator (S-ICD) compared with transvenous ICD (TV-ICD) showed non-inferiority S-ICD regard to composite endpoint device-related complications inappropriate shocks (IAS) after 49.1 months. Complications associated leads are expected occur longer follow-up. PRAETORIAN-XL aims investigate whether is superior TV-ICD respect at 8-year Methods: randomized patients a class I or IIa...
BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome the risk of lead-related complications associated with transvenous (TV-ICD). In contrast TV-ICD, S-ICD is a completely extrathoracic device. Subsequently, differ between these 2 cardioverter-defibrillators, which might impact patient perceptions therapies. This prespecified secondary analysis PRAETORIAN trial evaluates differences in quality life. METHODS: (A Prospective, Randomized...
The threshold to perform concomitant tricuspid valve (TV) repair during primary mitral (MV) surgery has decreased, based on recent randomized evidence. Based these developments, the indication for TV MV is expected increase further. However, concerns have been raised regarding risk of permanent pacemaker implantation (PPI) a procedure. Therefore, we aim assess incidence PPI in combined and nationwide registry. current study uniquely cross-linked Cardiothoracic Pacemaker/ICD registry...
BACKGROUND: Inappropriate therapy (IAT) is an undesirable side effect of implantable cardiac defibrillator (ICD) therapy. Early studies with the subcutaneous ICD (S-ICD) showed relatively high inappropriate shock (IAS) rates. The PRAETORIAN (Prospective Randomized Comparison Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) trial demonstrated that S-ICD noninferior to transvenous (TV-ICD) regard combined end point IAS complications. This secondary analyses...
Abstract Background There is an increasing number of smartwatches and devices commercially available that can generate automatically interpret electrocardiogram (ECG). Such have enormous potential to improve population screening telemonitoring atrial fibrillation (AF). Purpose limited data on the sensitivity, specificity interpretability these comparative studies are lacking. Our purpose was compare three frequently used for AF detection. Methods We performed a single-center, prospective...
Abstract Background There is an increasing number of smartwatches and devices commercially available that can generate automatically interpret electrocardiogram (ECG). Such have enormous potential to improve population screening telemonitoring atrial fibrillation (AF). Purpose limited data on the sensitivity, specificity interpretability these comparative studies are lacking. Our purpose was compare three frequently used for AF detection. Methods We performed a single-center, prospective...
Introduction: The randomized PRAETORIAN trial demonstrated non-inferiority of the subcutaneous implantable cardioverter-defibrillator (S-ICD) compared to transvenous ICD (TV-ICD) with regard inappropriate shocks and complications. Due its extrathoracic position, S-ICD lacks possibility provide antitachycardia pacing (ATP) which might result in more appropriate shock therapy. In this pre-specified secondary analysis, we aim compare first occurrence therapy TV-ICD. Methods: is an...